Technology
Health
Biotechnology

Actinium Pharmaceuticals

13,480

$0.1989
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0137 (+7.40%) As of 1:50 PM EDT today
+$0.0137 (+7.40%) Today

Why Robinhood?

You can buy or sell ATNM and other stocks, options, ETFs, and crypto commission-free!

About ATNM

Actinium Pharmaceuticals, Inc, also called Actinium Pharmaceuticals, is a clinical-stage, Biopharmaceutical Company focused on developing and potentially commercializing therapies to cell therapies. The firm's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells. Read More Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.

CEO
Sandesh Seth
Employees
30
Headquarters
New York, New York
Founded
1993
Market Cap
32.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.47M
High Today
$0.2001
Low Today
$0.186
Open Price
$0.1861
Volume
1.04M
52 Week High
$0.60
52 Week Low
$0.1685

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2013 IPO
US

ATNM Earnings

-$0.06
-$0.04
-$0.02
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 8, After Hours

People Also Bought

Onconova Therapeutics

26,687

$0.2948

+2.08%

Onconova Therapeutics

26,687

$0.2948

+2.08%

Titan Pharmaceuticals

37,346

$0.2223

-2.07%

Biocept

35,953

$0.2877

+1.23%

Inpixon

31,194

$1.23

+6.03%

You May Also Like

PAM
DFNS
VIE
DGII
EVTC
WMC
RBKB
AROC
XES
OVCHY
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ATNM

Market Price$0.1989
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ATNM stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up